Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024 11

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024 11

Study examines Kentucky cancer survivors' increased risk of cancer incidence

by Elizabeth Chapin,University of KentuckyCredit: Unsplash/CC0 Public DomainWhile cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentu

Updated on: February 20,2024 12

Study examines Kentucky cancer survivors' increased risk of cancer incidence

by Elizabeth Chapin,University of KentuckyCredit: Unsplash/CC0 Public DomainWhile cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentu

Updated on:February 20,2024 12

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by

Updated on: January 23,2024 14

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by

Updated on:January 23,2024 14

How tumors mutate their way out of a crisis—and become drug resistant in the process

byWeizmann Institute of ScienceHuman lung cancer cells under the microscope, before (left) and after (right) treatment with an anticancer drug, which causes DNA breaks (green) in the cell nuclei

Updated on: January 21,2024 18

How tumors mutate their way out of a crisis—and become drug resistant in the process

byWeizmann Institute of ScienceHuman lung cancer cells under the microscope, before (left) and after (right) treatment with an anticancer drug, which causes DNA breaks (green) in the cell nuclei

Updated on:January 21,2024 18

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on: August 26,2024 0

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on:August 26,2024 0

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on: February 20,2024 18

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on:February 20,2024 18

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Updated on: August 27,2024 0

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Updated on:August 27,2024 0

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on: March 21,2024 13

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on:March 21,2024 13

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on: June 01,2024 8

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi

Updated on:June 01,2024 8

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on: March 12,2024 12

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on:March 12,2024 12

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on: May 13,2024 5

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on:May 13,2024 5

Cancer survivors who quit smoking found to have 36% lower cardiovascular risk than those who continue

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainCancer patients who continue smoking after their diagnosis have a nearly doubled risk of heart attack, stroke or death due to car

Updated on: January 23,2024 20

Cancer survivors who quit smoking found to have 36% lower cardiovascular risk than those who continue

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainCancer patients who continue smoking after their diagnosis have a nearly doubled risk of heart attack, stroke or death due to car

Updated on:January 23,2024 20